Jennison Associates LLC Haemonetics Corp Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$80.59 - $92.61 $322 - $370	-4 Reduced 0.06%	6,806 $581,000
Q3 2023 Oct 31, 2023	SELL	$82.56 - $93.49 $147,452 - $166,973	-1,786 Reduced 20.78%	6,810 $610,000
Q2 2023 Aug 03, 2023	SELL	$80.84 - $89.45 $66,531 - $73,617	-823 Reduced 8.74%	8,596 $731,000
Q1 2023 Apr 26, 2023	SELL	$72.75 - $90.6 $28,445 - $35,424	-391 Reduced 3.99%	9,419 $779,000
Q4 2022 Feb 09, 2023	BUY	$73.85 - $86.14 $13,440 - $15,677	182 Added 1.89%	9,810 $771,000
Q3 2022 Nov 01, 2022	BUY	$63.3 - $78.66 $609,452 - $757,338	9,628 New	9,628 $713,000

349

55.7M

600K

474K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.23B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.